All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-32105319

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32105319	A98G	RT	gag-pol	HIV Infections	D G R C L	View
2	32105319	D67N	RT	gag-pol	HIV Infections	D G R C L	View
3	32105319	E138K	IN	gag-pol	HIV Infections	D G R C L	View
4	32105319	E157Q	IN	gag-pol	HIV Infections	D G R C L	View
5	32105319	E44D	RT	gag-pol	HIV Infections	D G R C L	View
6	32105319	G140A	IN	gag-pol	HIV Infections	D G R C L	View
7	32105319	G190A	RT	gag-pol	HIV Infections	D G R C L	View
8	32105319	H221Y	RT	gag-pol	HIV Infections	D G R C L	View
9	32105319	I54V	RT	gag-pol	HIV Infections	D G R C L	View
10	32105319	K101E	RT	gag-pol	HIV Infections	D G R C L	View
11	32105319	K101H	RT	gag-pol	HIV Infections	D G R C L	View
12	32105319	K103N	RT	gag-pol	HIV Infections	D G R C L	View
13	32105319	K219E	RT	gag-pol	HIV Infections	D G R C L	View
14	32105319	K219Q	RT	gag-pol	HIV Infections	D G R C L	View
15	32105319	K238T	RT	gag-pol	HIV Infections	D G R C L	View
16	32105319	K65R	RT	gag-pol	HIV Infections	D G R C L	View
17	32105319	K70E	RT	gag-pol	HIV Infections	D G R C L	View
18	32105319	K70R	RT	gag-pol	HIV Infections	D G R C L	View
19	32105319	L10F	RT	gag-pol	HIV Infections	D G R C L	View
20	32105319	L24I	PR	gag-pol	HIV Infections	D G R C L	View
21	32105319	L33F	PR	gag-pol	HIV Infections	D G R C L	View
22	32105319	L74I	IN	gag-pol	HIV Infections	D G R C L	View
23	32105319	L74L	IN	gag-pol	HIV Infections	D G R C L	View
24	32105319	L74V	IN	gag-pol	HIV Infections	D G R C L	View
25	32105319	L90M	PR	gag-pol	HIV Infections	D G R C L	View
26	32105319	M184V	RT	gag-pol	HIV Infections	D G R C L	View
27	32105319	M41L	RT	gag-pol	HIV Infections	D G R C L	View
28	32105319	M46I	PR	gag-pol	HIV Infections	D G R C L	View
29	32105319	N348I	RT	gag-pol	HIV Infections	D G R C L	View
30	32105319	P225H	RT	gag-pol	HIV Infections	D G R C L	View
31	32105319	Q148K	IN	gag-pol	HIV Infections	D G R C L	View
32	32105319	R263K	IN	gag-pol	HIV Infections	D G R C L	View
33	32105319	T215F	RT	gag-pol	HIV Infections	D G R C L	View
34	32105319	T215I	RT	gag-pol	HIV Infections	D G R C L	View
35	32105319	T215Y	RT	gag-pol	HIV Infections	D G R C L	View
36	32105319	T69D	RT	gag-pol	HIV Infections	D G R C L	View
37	32105319	T97A	IN	gag-pol	HIV Infections	D G R C L	View
38	32105319	V108I	RT	gag-pol	HIV Infections	D G R C L	View
39	32105319	V179E	RT	gag-pol	HIV Infections	D G R C L	View
40	32105319	V179L	RT	gag-pol	HIV Infections	D G R C L	View
41	32105319	V179M	RT	gag-pol	HIV Infections	D G R C L	View
42	32105319	V179V	RT	gag-pol	HIV Infections	D G R C L	View
43	32105319	V75I	RT	gag-pol	HIV Infections	D G R C L	View
44	32105319	V75M	RT	gag-pol	HIV Infections	D G R C L	View
45	32105319	V82A	PR	gag-pol	HIV Infections	D G R C L	View
46	32105319	V82S	PR	gag-pol	HIV Infections	D G R C L	View
47	32105319	Y115F	RT	gag-pol	HIV Infections	D G R C L	View
48	32105319	Y181C	RT	gag-pol	HIV Infections	D G R C L	View
49	32105319	Y318F	RT	gag-pol	HIV Infections	D G R C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.